Literature DB >> 21999935

Meta-analysis of predictive factors and outcomes for failure of non-operative management of blunt splenic trauma.

Aneel Bhangu1, Dmitri Nepogodiev, Neeraj Lal, Douglas M Bowley.   

Abstract

BACKGROUND: This study aimed to analyse predictive factors and outcomes of failure of non-operative management (NOM) following blunt splenic trauma.
METHODS: A systematic review of the literature was performed for studies comparing failed NOM (fNOM) to successful NOM (sNOM) in adults (≥ 16 years). The main endpoints were fNOM and associated mortality. Between-study heterogeneity was assessed. Meta-analysis of high quality studies, identified using the Newcastle-Ottawa Scale, was performed using fixed or random models.
RESULTS: Four prospective and 21 retrospective studies were included. From 24,615 unselected patients, 3025 experienced fNOM (12%, range 4-52%). Meta-analysis of the high quality studies revealed that mortality was significantly higher with fNOM in unselected age groups (odds ratio 1.93, 95% confidence interval 1.04-3.57, p = 0.04, I(2) = 0%), in those <55 years old (OR 3.42, 95% CI 1.73-6.77, p = 0.02, I(2) = 0%) and in those ≥ 55 years old (OR 2.65, 95% CI 1.20-5.82, p = 0.02, I(2) = 0%). There was a significant improvement in sNOM following introduction of angioembolisation protocols (OR 0.26, 95% CI 0.13-0.53, p<0.002, I(2) = 51%), although these five studies were non-randomised. American Association for the Surgery of Trauma injury grades 4-5, the presence of moderate or large haemoperitoneum, increasing injury severity score and increasing age were all significantly associated with increased risk of fNOM. fNOM led to significantly longer intensive care unit and overall lengths of stay.
CONCLUSIONS: fNOM leads to increased resource use and increased mortality. Methods of preventing fNOM, such as angioembolisation, warrant further assessment. Patients with increasing age, AAST scores and moderate or large haemoperitoneums may benefit from closer monitoring.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21999935     DOI: 10.1016/j.injury.2011.09.010

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  20 in total

1.  Splenic trauma in the twenty-first century: changing trends in management.

Authors:  P Roy; R Mukherjee; M Parik
Journal:  Ann R Coll Surg Engl       Date:  2018-08-16       Impact factor: 1.891

2.  Impact of anatomic location on locally recurrent rectal cancer: superior outcome for intraluminal tumour recurrence.

Authors:  Johannes Klose; Ignazio Tarantino; Thomas Schmidt; Thomas Bruckner; Yakup Kulu; Tobias Wagner; Martin Schneider; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2015-03-31       Impact factor: 3.452

3.  The need for red blood cell transfusions in the emergency department as a risk factor for failure of non-operative management of splenic trauma: a multicenter prospective study.

Authors:  Paola Fugazzola; Lucia Morganti; Federico Coccolini; Stefano Magnone; Giulia Montori; Marco Ceresoli; Matteo Tomasoni; Dario Piazzalunga; Stefano Maccatrozzo; Niccolò Allievi; Savino Occhionorelli; Luca Ansaloni
Journal:  Eur J Trauma Emerg Surg       Date:  2018-10-15       Impact factor: 3.693

Review 4.  Follow-up strategies for patients with splenic trauma managed non-operatively: the 2022 World Society of Emergency Surgery consensus document.

Authors:  Mauro Podda; Belinda De Simone; Marco Ceresoli; Francesco Virdis; Francesco Favi; Johannes Wiik Larsen; Federico Coccolini; Massimo Sartelli; Nikolaos Pararas; Solomon Gurmu Beka; Luigi Bonavina; Raffaele Bova; Adolfo Pisanu; Fikri Abu-Zidan; Zsolt Balogh; Osvaldo Chiara; Imtiaz Wani; Philip Stahel; Salomone Di Saverio; Thomas Scalea; Kjetil Soreide; Boris Sakakushev; Francesco Amico; Costanza Martino; Andreas Hecker; Nicola de'Angelis; Mircea Chirica; Joseph Galante; Andrew Kirkpatrick; Emmanouil Pikoulis; Yoram Kluger; Denis Bensard; Luca Ansaloni; Gustavo Fraga; Ian Civil; Giovanni Domenico Tebala; Isidoro Di Carlo; Yunfeng Cui; Raul Coimbra; Vanni Agnoletti; Ibrahima Sall; Edward Tan; Edoardo Picetti; Andrey Litvin; Dimitrios Damaskos; Kenji Inaba; Jeffrey Leung; Ronald Maier; Walt Biffl; Ari Leppaniemi; Ernest Moore; Kurinchi Gurusamy; Fausto Catena
Journal:  World J Emerg Surg       Date:  2022-10-12       Impact factor: 8.165

5.  External Attention Assisted Multi-Phase Splenic Vascular Injury Segmentation With Limited Data.

Authors:  Yuyin Zhou; David Dreizin; Yan Wang; Fengze Liu; Wei Shen; Alan L Yuille
Journal:  IEEE Trans Med Imaging       Date:  2022-06-01       Impact factor: 11.037

6.  Non operative management of blunt splenic trauma: a prospective evaluation of a standardized treatment protocol.

Authors:  A Brillantino; F Iacobellis; U Robustelli; E Villamaina; F Maglione; O Colletti; M De Palma; F Paladino; G Noschese
Journal:  Eur J Trauma Emerg Surg       Date:  2015-09-28       Impact factor: 3.693

Review 7.  Literature review of non-operative management of patients with blunt splenic injury: impact of splenic artery embolization.

Authors:  Krystyn Sosada; Maciej Wiewióra; Jerzy Piecuch
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-07-23       Impact factor: 1.195

8.  Observation Versus Embolization in Patients with Blunt Splenic Injury After Trauma: A Propensity Score Analysis.

Authors:  Dominique C Olthof; Pieter Joosse; Patrick M M Bossuyt; Philippe P de Rooij; Loek P H Leenen; Klaus W Wendt; Frank W Bloemers; J Carel Goslings
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

9.  Non-operative management attempted for selective high grade blunt hepatosplenic trauma is a feasible strategy.

Authors:  Ting-Min Hsieh; Tsung Cheng Tsai; Jiun-Lung Liang; Chih Che Lin
Journal:  World J Emerg Surg       Date:  2014-09-25       Impact factor: 5.469

Review 10.  MAIN CONTROVERSIES IN THE NONOPERATIVE MANAGEMENT OF BLUNT SPLENIC INJURIES.

Authors:  Jorge Roberto Marcante Carlotto; Gaspar de Jesus Lopes-Filho; Ramiro Colleoni-Neto
Journal:  Arq Bras Cir Dig       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.